by Truveta Research | Mar 6, 2024 | Research, Research Insights
Disparities in time to treatment and treatment outcomes exist for people with severe aortic stenosis receiving TAVR and SAVR procedures. We studied the rate of people who receive TAVR, SAVR, aortic valve repair, and aortic balloon valvuloplasty procedures and time to...
by Truveta Research | Feb 22, 2024 | Research, Research Insights
Aortic stenosis – the narrowing of the valve between the lower left heart chamber (left ventricle) and the aorta – is commonly diagnosed with an echocardiogram and staged according to the disease progression. However, it’s a difficult condition to study across large...
by Truveta Research | Feb 7, 2024 | Research, Research Insights
We found 13.1 emergency department visits for falls on snow or ice per 10,000 emergency department visits during wintery months; with 3x higher rates happening in states with freezing temperatures during the winters compared to states with milder winters. Wrist...
by Truveta Research | Jan 11, 2024 | Research, Research Insights
There is a complex relationship between cannabis use and mental health. We studied recent time trends of the rate of cannabis-induced disorder emergency department visits and cannabis-involved emergency department visits (both defined below). Between 2019 and 2020, we...
by Truveta Research | Nov 27, 2023 | Research, Research Insights
Today Truveta announced new comparative effectiveness research exploring weight loss among patients taking semaglutide (Ozempic) and tirzepatide (Mounjaro). Glucagon-like peptide 1 receptor agonist-based (GLP-1 RA) medications, including semaglutide and the dual GLP-1...
by Truveta Research | Nov 10, 2023 | Research, Research Insights
Adequate treatments are a crucial piece in the fight against the spread of HIV, because they can make HIV viral load undetectable in the blood and thus untransmittable. Approved by the US Food and Drug Administration (FDA) in January 2021, one of the newest treatments...
